Advertisement
CVS vs HUM
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVS is a Hold and HUM is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CVS’s FA Score shows that 3 FA rating(s) are green whileHUM’s FA Score has 0 green FA rating(s).
- CVS’s FA Score: 3 green, 2 red.
- HUM’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CVS’s TA Score shows that 5 TA indicator(s) are bullish while HUM’s TA Score has 6 bullish TA indicator(s).
- CVS’s TA Score: 5 bullish, 5 bearish.
- HUM’s TA Score: 6 bullish, 4 bearish.
Price Growth
CVS (@Publishing: Books/Magazines) experienced а +4.67% price change this week, while HUM (@Publishing: Books/Magazines) price change was +7.39% for the same time period.
The average weekly price growth across all stocks in the @Publishing: Books/Magazines industry was +4.60%. For the same industry, the average monthly price growth was -0.03%, and the average quarterly price growth was -10.10%.
Reported Earning Dates
CVS is expected to report earnings on Oct 29, 2025.
HUM is expected to report earnings on Nov 05, 2025.
Industries' Descriptions
@Publishing: Books/Magazines (+4.60% weekly)The industry includes companies that publish and market books and magazines/periodicals. John Wiley & Sons, Inc., Meredith Corporation and Scholastic Corporation are some of the biggest companies in this industry. Like many other industries, publishing companies have branched out into online/digital publications (while retaining their original print business), to capture the burgeoning market in electronic media. Business could be cyclical in certain cases, since weak consumer sentiment during an economic downturn might depress sales of some magazines and books.
| CVS | HUM | CVS / HUM | |
| Capitalization | 87B | 34.4B | 253% |
| EBITDA | 14.2B | N/A | - |
| Gain YTD | 58.061 | 13.671 | 425% |
| P/E Ratio | 19.11 | 21.95 | 87% |
| Revenue | 387B | 123B | 315% |
| Total Cash | 14.2B | 21.7B | 65% |
| Total Debt | 82.7B | 12.6B | 656% |
CVS | HUM | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 14 | 14 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 16 Undervalued | 41 Fair valued | |
PROFIT vs RISK RATING 1..100 | 78 | 100 | |
SMR RATING 1..100 | 80 | 97 | |
PRICE GROWTH RATING 1..100 | 29 | 43 | |
P/E GROWTH RATING 1..100 | 11 | 69 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CVS's Valuation (16) in the Drugstore Chains industry is in the same range as HUM (41) in the Managed Health Care industry. This means that CVS’s stock grew similarly to HUM’s over the last 12 months.
CVS's Profit vs Risk Rating (78) in the Drugstore Chains industry is in the same range as HUM (100) in the Managed Health Care industry. This means that CVS’s stock grew similarly to HUM’s over the last 12 months.
CVS's SMR Rating (80) in the Drugstore Chains industry is in the same range as HUM (97) in the Managed Health Care industry. This means that CVS’s stock grew similarly to HUM’s over the last 12 months.
CVS's Price Growth Rating (29) in the Drugstore Chains industry is in the same range as HUM (43) in the Managed Health Care industry. This means that CVS’s stock grew similarly to HUM’s over the last 12 months.
CVS's P/E Growth Rating (11) in the Drugstore Chains industry is somewhat better than the same rating for HUM (69) in the Managed Health Care industry. This means that CVS’s stock grew somewhat faster than HUM’s over the last 12 months.
| CVS | HUM | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 53% | 2 days ago 66% |
| Stochastic ODDS (%) | 2 days ago 62% | 2 days ago 66% |
| Momentum ODDS (%) | 2 days ago 66% | 2 days ago 65% |
| MACD ODDS (%) | 2 days ago 60% | 2 days ago 60% |
| TrendWeek ODDS (%) | 2 days ago 60% | 2 days ago 60% |
| TrendMonth ODDS (%) | 2 days ago 57% | 2 days ago 58% |
| Advances ODDS (%) | 2 days ago 63% | 4 days ago 60% |
| Declines ODDS (%) | 30 days ago 58% | 16 days ago 65% |
| BollingerBands ODDS (%) | 2 days ago 60% | 2 days ago 74% |
| Aroon ODDS (%) | 2 days ago 58% | 2 days ago 51% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BSJS | 22.10 | 0.01 | +0.04% |
| Invesco BulletShares 2028 HY Corp Bd ETF | |||
| CDEI | 76.90 | N/A | N/A |
| Calvert US Large-Cp Div, Eq AndIncETF | |||
| SMAX | 26.47 | N/A | N/A |
| iShares Large Cap Max Buffer Sep ETF | |||
| VSMV | 50.98 | -0.02 | -0.04% |
| VictoryShares US Mult-Fctr Mnmm Vltl ETF | |||
| USCA | 40.03 | -0.02 | -0.05% |
| Xtrackers MSCI USA Clmt Actn Eq ETF | |||